Delivery Order SPE2DR25D2014-SPE2DR26FA4D1
Award Date 1/29/26
Potential Completion Date 1/30/26
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,916.10 to AmerisourceBergen Drug Corp for the supply of Creon DR 36,000 unit capsules (100 count) on January 12, 2026, with completion scheduled for January 13, 2026. This non-competitive delivery order utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant...
- On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $14,054.31 to AmerisourceBergen Drug Corp for the supply of Creon DR 36,000 unit capsules in quantities of 100 units. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a non-competitive task order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,555.41 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Creon (pancrelipase) capsules—24,000 units in 100-count bottles. This non-competitive, firm fixed-price delivery order is scheduled for completion by January 16, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for 36,000 unit capsules of Creon DR 100s, with a ceiling value of $1,641.42 and an ultimate completion date of January 30, 2026. This is a firm fixed-price delivery order executed without set-aside designation, reflecting open and competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,703.20 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, with delivery scheduled by December 16, 2025. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The contract type utilizes firm fixed pricing and represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,629.96 to AmerisourceBergen Drug Corp for 12,000 unit capsules of Creon (pancreatic enzyme replacement therapy) on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price, competitively awarded contract—which carries no set-aside designation—will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,013.90 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on January 28, 2026, with an ultimate completion date of January 29, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The contractor will perform this delivery from its facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of 12,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement medication used to treat pancreatic insufficiency. The contract is valued at $7,031.95 with a firm fixed-price structure and an ultimate completion date of January 20, 2026. This delivery order was awarded on a fully competitive basis with no set-aside designation and represents a task order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,860.27 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancrelipase) in 100-count bottles. This competitive, firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $11,226.15 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on January 28, 2026, with completion targeted for January 29, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the contractor's Conshohocken,...